Skip to the page

Data / Form D filings / descendantsDNA, Inc.

descendantsDNA, Inc.: Form D filing

descendantsDNA, Inc., a health care company in Houston, TX, filed a Form D with the SEC in 2025. The latest, on February 13, 2025, reports $3.4 million sold of a $6 million offering to 30 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2617 BISSONNET, SUITE 219, Houston, TX, 77005
Phone
(713) 494-9484
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Nevada
Year incorporated
2021
Revenue range
$1 - $1,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2056109

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 13, 2025New notice$6,000,000$3,395,500$2,604,50030Mar 8, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Donnie W DeanDirector
Francisco J BangoDirector
Rod CutsingerExecutive Officer, Director
Reynolds J DelgadoDirector
Newton W WilsonExecutive Officer, Director

Other health care companies in Texas that filed recently

Every Form D from the week of Feb 10, 2025 · All recent filings in Texas · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what descendantsDNA, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.